KR100587445B1 - 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도 - Google Patents
에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도 Download PDFInfo
- Publication number
- KR100587445B1 KR100587445B1 KR1019990052014A KR19990052014A KR100587445B1 KR 100587445 B1 KR100587445 B1 KR 100587445B1 KR 1019990052014 A KR1019990052014 A KR 1019990052014A KR 19990052014 A KR19990052014 A KR 19990052014A KR 100587445 B1 KR100587445 B1 KR 100587445B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- ppm
- methyl
- substituted
- Prior art date
Links
- 0 CC[C@]([C@](C)(C=C(C)C([C@](C)C[C@](C)([C@@]([C@@](C)C([C@]1(C)*)=O)O[C@@]([C@]2ON)O[C@](C)C[C@@]2N(C)C)OC)=O)OC([n]2cncc2)=O)OC1=O Chemical compound CC[C@]([C@](C)(C=C(C)C([C@](C)C[C@](C)([C@@]([C@@](C)C([C@]1(C)*)=O)O[C@@]([C@]2ON)O[C@](C)C[C@@]2N(C)C)OC)=O)OC([n]2cncc2)=O)OC1=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
번호 | 1H | 번호 | 1H |
1 | 1' | 4.28 | |
2 | 3.86 | 2' | 3.16 |
3 | 3' | 2.44 | |
4 | 3.07 | 4' | 1.67-1.23 |
5 | 4.21 | 5' | 3.52 |
6 | 5'Me | 1.24 | |
7 | 1.59-1.82 | N(Me)2 | 2.26 |
8 | 2.60 | NCH2 | 3.60 내지 3.80 |
9 | CH2 | 1.65 | |
10 | 3.13 | CH2 | 1.95 |
11 | 3.57 | CH2N | 4.21 |
12 | 피라졸 H4 | 6.55 | |
13 | 4.94 | 피라졸 H5 | 7.47 |
14 | 1.95-1.57 | 피리딘 | |
15 | 0.85 | H2 | 9.00 |
2Me | 1.36 | H4 | 8.11 |
4Me | 1.31 | H5 | 7.31 |
6Me | 1.33 또는 1.47 | H6 | 8.51 |
8Me | 1.16 | ||
10Me | 1.00 | ||
12Me | 1.33 또는 1.47 | ||
60Me | 2.60 |
그람 양성 박테리아 균주 | ||
스타필로코커스 아우레우스 (Staphylococcus aureus) | 011UC4 | 0.040 |
스타필로코커스 아우레우스 | 011UC4+ 50% 혈청 | 0.600 |
스타필로코커스 아우레우스 | 011B18c | |
스타필로코커스 아우레우스 | 011GR12c | |
스타필로코커스 아우레우스 | 011GO25i | 0.600 |
스타필로코커스 에피더미디스(S. epidermidis) | 012GO11i | 0.040 |
스타필로코커스 아우레우스 | 011CB20c | |
스타필로코커스 에피더미디스 | 012GO40c | |
스타필로코커스 파이오제네스(S. pyogenes) | 02A1UC1 | 0.02 |
스트렙토코커스 아갈락티애 (Streptococcus agalactiae) | 02B1HT1 | 0.02 |
스트렙토코커스 패칼리스(S. faecalis) | 02D2UC1 | 0.02 |
스트렙토코커스 패슘(S. faecium) | 02D3HT1 | 0.02 |
스트렙토코커스 그람 양성 | 02GOGR5 | 0.02 |
스트렙토코커스 미티스(S. mitis) | 02MitCB1 | 0.02 |
스트렙토코커스 아갈락티애 | 02B1SJ1c | 0.050 |
스트렙토코커스 패칼리스 | 02D2DU15c | 5.000 |
스트렙토코커스 그람 양성 | 02Gogr4c | |
스트렙토코커스 산퀴스(S. sanquis) | 02SGr10i | 0.02 |
스트렙토코커스 미티스 | 02MitGR16i | 0.02 |
스트렙토코커스 뉴모니애(S. pneumoniae) | 032UC1 | 0.02 |
스트렙토코커스 뉴모니애 | 030GR20 | 0.02 |
스트렙토코커스 뉴모니애 | 030SJ5i | 0.040 |
스트렙토코커스 뉴모니애 | 030CR18c | 0.300 |
스트렙토코커스 뉴모니애 | 030PW23c | 0.02 |
스트렙토코커스 뉴모니애 | 030RO1i | 0.150 |
스트렙토코커스 뉴모니애 | 030SJ1c | 0.150 |
Claims (12)
- 하기 화학식 1의 화합물 및 그의 산부가염.<화학식 1>식 중, Y는 수소 원자 또는 플루오르 원자를 나타내고,n은 1 내지 8의 정수를 나타내고,Z는 수소 원자 또는 카르복실산 잔기를 나타내며,피라졸 고리는 1 개 이상의, 탄소 원자수 14 이하의 아릴기 또는 하나 이상의 질소, 산소 또는 황 원자를 함유하는 헤테로아릴기로 치환되고,아릴 또는 헤테로아릴기는 탄소 원자수 8 이하의 하나 이상의 알킬, 알케닐, 알키닐, O-알킬, O-알케닐, O-알키닐, S-알킬, S-알케닐, S-알키닐기, 하나 이상의 OH, NH2, C≡N, NO2 또는 CF3기로 치환될 수 있다.
- 제1항에 있어서, Z가 수소 원자를 나타내는 화학식 1의 화합물.
- 제1항 또는 제2항에 있어서, n이 4를 나타내는 화학식 1의 화합물.
- 제1항에 있어서, Y가 수소 원자를 나타내는 화학식 1의 화합물.
- 제1항의 화학식 1의 화합물 중 11,12-디데옥시-3-데[(2,6-디데옥시 -3-C-메틸-3-O-메틸-알파-L-리보헥소피라노실)옥시]-6-O-메틸-3-옥소-12,11-[옥시카르보닐[[4-[3-(3-피리디닐)-1H-피라졸-1-일]부틸]이미노]]-에리트로마이신의 화합물.
- 제1항 또는 제2항의 화학식 1의 화합물 및 그의 제약학상 허용가능한 산과의 부가염을 포함하는, 병원체 -민감성 감염증 치료용 제약 조성물.
- 제6항의 화학식 1의 화합물 및 제약학상 허용가능한 산과의 부가염을 포함하는, 병원체 -민감성 감염증 치료용 제약 조성물.
- 삭제
- 하기 화학식 2의 화합물을 하기 화학식 3의 화합물과 반응시켜 Z가 산 잔기를 나타내는 제1항 기재의 화학식 1의 화합물을 얻고, 필요하다면 상기 화학식 1의 화합물을 2' 위치의 히드록실을 유리시키는 화합물과 작용시켜서 Z가 수소 원자를 나타내는 제1항 또는 제2항 기재의 화학식 1의 상응하는 화합물을 얻고, 필요하다면 염을 형성하기 위해 산을 작용시키는 것을 특징으로 하는, 제1항 또는 제2항 기재의 화학식 1의 화합물의 제조 방법.<화학식 2>식 중, Y는 제1항 또는 제2항에서 정의된 바와 같으며, M은 산 잔기를 나타낸다.<화학식 3>식 중, 피라졸 고리는 제1항에 정의된 바와 같이 치환되고, n은 제1항에 정의된 바와 같다.
- 1-(3-아미노프로필)-3,4-디페닐-1H-피라졸을 제외한, 신규한 화학 생성물로서 제10항 기재의 화학식 3의 화합물.
- 제11항 기재의 신규한 화학 생성물로서, 화학식 3의 화합물 중 3-(3-피리디닐)-1H-피라졸-1-부탄아민 또는 4-(3-피리디닐)-1H-피라졸-1-부탄아민의 화합물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR98/14782 | 1998-11-24 | ||
FR9814782A FR2786188B1 (fr) | 1998-11-24 | 1998-11-24 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000057017A KR20000057017A (ko) | 2000-09-15 |
KR100587445B1 true KR100587445B1 (ko) | 2006-06-08 |
Family
ID=9533122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990052014A KR100587445B1 (ko) | 1998-11-24 | 1999-11-23 | 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도 |
Country Status (24)
Country | Link |
---|---|
US (2) | US6440941B1 (ko) |
EP (1) | EP1004592B1 (ko) |
JP (1) | JP2000159790A (ko) |
KR (1) | KR100587445B1 (ko) |
CN (1) | CN1165546C (ko) |
AR (1) | AR021388A1 (ko) |
AT (1) | ATE245160T1 (ko) |
AU (1) | AU772171B2 (ko) |
BR (1) | BR9905735A (ko) |
CA (1) | CA2290136C (ko) |
DE (1) | DE69909577T2 (ko) |
DK (1) | DK1004592T3 (ko) |
ES (1) | ES2198867T3 (ko) |
FR (1) | FR2786188B1 (ko) |
HU (1) | HUP9904392A3 (ko) |
IL (1) | IL133101A (ko) |
MX (1) | MXPA99010813A (ko) |
NO (1) | NO314729B1 (ko) |
PL (1) | PL336736A1 (ko) |
PT (1) | PT1004592E (ko) |
RU (1) | RU2237672C2 (ko) |
TR (1) | TR199902888A2 (ko) |
TW (1) | TWI247747B (ko) |
ZA (1) | ZA997176B (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
SI1147121T1 (en) | 1999-01-27 | 2004-04-30 | Pfizer Products Inc. | Ketolide antibiotics |
EE200100613A (et) | 1999-05-24 | 2003-02-17 | Pfizer Products Inc. | 13-metüülerütromütsiini derivaadid |
TR200401847T4 (tr) | 2000-06-30 | 2004-09-21 | Pfizer Products Inc. | Makrolit antibiyotikler. |
EP2772254A3 (en) | 2003-03-10 | 2015-03-11 | Optimer Pharmaceuticals, Inc. | Novel Antibacterial Agents |
FR2862647B1 (fr) | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
US20080287376A1 (en) * | 2004-07-28 | 2008-11-20 | Mohammad Salman | Ketolide Derivatives as Antibacterial Agents |
JP5698979B2 (ja) * | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ,インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
US8552162B2 (en) * | 2008-05-09 | 2013-10-08 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives |
CN105616437A (zh) * | 2008-10-24 | 2016-06-01 | 森普拉制药公司 | 使用含三唑的大环内酯的生物防御 |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
CN108310000A (zh) | 2009-09-10 | 2018-07-24 | 森普拉制药公司 | 治疗疟疾、结核病和mac疾病的方法 |
EP3009442B1 (en) | 2010-03-22 | 2019-06-19 | Cempra Pharmaceuticals, Inc. | Crystalline forms of a macrolide, and uses therefor |
DK2571506T3 (en) | 2010-05-20 | 2017-08-28 | Cempra Pharmaceuticals Inc | PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES |
US9815863B2 (en) * | 2010-09-10 | 2017-11-14 | Cempra Pharmaceuticals, Inc. | Hydrogen bond forming fluoro ketolides for treating diseases |
WO2012052412A1 (de) | 2010-10-22 | 2012-04-26 | Bayer Cropscience Ag | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
RU2658050C2 (ru) | 2012-03-27 | 2018-06-19 | Семпра Фармасьютикалз, Инк. | Парентеральные составы для введения макролидных антибиотиков |
JP6426696B2 (ja) | 2013-03-14 | 2018-11-21 | センプラ ファーマシューティカルズ,インコーポレイテッド | 呼吸器疾患の治療のための方法および製剤 |
CA2907085A1 (en) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
CN106432383A (zh) * | 2016-09-14 | 2017-02-22 | 重庆两江药物研发中心有限公司 | 索利霉素及其中间体的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4182895A (en) * | 1976-12-20 | 1980-01-08 | Sterling Drug Inc. | 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1098527A (en) * | 1976-12-20 | 1981-03-31 | Denis M. Bailey | 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles |
JPH04234891A (ja) * | 1990-03-05 | 1992-08-24 | Fujisawa Pharmaceut Co Ltd | 新規セフェム化合物およびその塩 |
FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
JP2000513026A (ja) * | 1997-06-11 | 2000-10-03 | ファイザー・プロダクツ・インク | 9−オキシム エリスロマイシン誘導体 |
FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
-
1998
- 1998-11-24 FR FR9814782A patent/FR2786188B1/fr not_active Expired - Fee Related
-
1999
- 1999-11-16 TW TW088119939A patent/TWI247747B/zh not_active IP Right Cessation
- 1999-11-17 AU AU59522/99A patent/AU772171B2/en not_active Expired
- 1999-11-18 CA CA2290136A patent/CA2290136C/fr not_active Expired - Lifetime
- 1999-11-18 US US09/442,681 patent/US6440941B1/en not_active Expired - Lifetime
- 1999-11-18 ZA ZA9907176A patent/ZA997176B/xx unknown
- 1999-11-22 JP JP11331141A patent/JP2000159790A/ja active Pending
- 1999-11-23 MX MXPA99010813A patent/MXPA99010813A/es active IP Right Grant
- 1999-11-23 AT AT99402907T patent/ATE245160T1/de active
- 1999-11-23 RU RU99125547A patent/RU2237672C2/ru not_active IP Right Cessation
- 1999-11-23 IL IL133101A patent/IL133101A/en not_active IP Right Cessation
- 1999-11-23 EP EP99402907A patent/EP1004592B1/fr not_active Expired - Lifetime
- 1999-11-23 ES ES99402907T patent/ES2198867T3/es not_active Expired - Lifetime
- 1999-11-23 DE DE69909577T patent/DE69909577T2/de not_active Expired - Lifetime
- 1999-11-23 CN CNB99127394XA patent/CN1165546C/zh not_active Expired - Lifetime
- 1999-11-23 PT PT99402907T patent/PT1004592E/pt unknown
- 1999-11-23 HU HU9904392A patent/HUP9904392A3/hu unknown
- 1999-11-23 NO NO19995745A patent/NO314729B1/no unknown
- 1999-11-23 KR KR1019990052014A patent/KR100587445B1/ko active IP Right Grant
- 1999-11-23 DK DK99402907T patent/DK1004592T3/da active
- 1999-11-24 AR ARP990105985A patent/AR021388A1/es not_active Application Discontinuation
- 1999-11-24 TR TR1999/02888A patent/TR199902888A2/xx unknown
- 1999-11-24 BR BR9905735-2A patent/BR9905735A/pt active Search and Examination
- 1999-11-24 PL PL99336736A patent/PL336736A1/xx not_active Application Discontinuation
-
2002
- 2002-07-02 US US10/188,394 patent/US6664398B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4182895A (en) * | 1976-12-20 | 1980-01-08 | Sterling Drug Inc. | 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100587445B1 (ko) | 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도 | |
US6054435A (en) | 6-O-substituted macrolides having antibacterial activity | |
KR100319358B1 (ko) | 신규에리트로마이신 유도체, 그의 제조방법 및 의약으로서의 그의 용도 | |
JP4102440B2 (ja) | 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用 | |
KR100567695B1 (ko) | 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도 | |
HU219599B (hu) | 11,12-Didezoxi-3-dez(2,6-didezoxi-3-C-metil-3-O-metil-alfa-L-ribohexopiranozil-oxi)-6-O-metil-3-oxo-12,11-(oxi-karbonil-((4-(4-(3-piridinil)-1H-imidazol-1-il)-butil)-imino))-eritromicin, előállítása, e vegyületet tartalmazó gyógyászati készítmények ... | |
US6313101B1 (en) | Derivatives of erythromycin, their preparation process and their use as medicaments | |
KR100458240B1 (ko) | 신규 에리트로마이신 유도체, 그의 제조방법 및 의약으로서의용도 | |
KR100490074B1 (ko) | 신규한 에리트로마이신 유도체, 그의 제조 방법 및 의약품으로서의 그의 용도 | |
JP4522496B2 (ja) | 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用 | |
CZ417699A3 (cs) | Nové deriváty erythromycinu, způsob jejich přípravy a jejich použití jako léčiv | |
CZ2001237A3 (cs) | Nové deriváty 6-deoxyerytromycinu, způsob jejich přípravy a jejich pouľití jako léčiva | |
MXPA99000571A (en) | New derivatives of erythromycin, its procedure for preparation and its application as a medicine | |
MXPA99005840A (en) | Novel erythromycin derivatives, method of preparation and application as medicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130502 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140508 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150430 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160427 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170504 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180427 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190429 Year of fee payment: 14 |